AI assistant
Sending…
FENNEC PHARMACEUTICALS INC. — Director's Dealing 2021
Jun 30, 2021
35599_dirs_2021-06-30_a06191b4-32a8-4cee-8e2d-4b9c6b8d3250.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2021-06-29
Reporting Person: Brughera Marco Maria (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-06-29 | Stock Option (right to buy) | $7.52 | A | 20000 | Acquired | 2031-06-29 | Common Shares (20000) | Direct |
Footnotes
F1: On June 29, 2021, Marco Brughera was granted a non-qualified stock option to purchase 20,000 shares of the Issuer's common shares pursuant to the Issuer's Equity Incentive Plan.
F2: The option is 100% vested on the date of grant.
More from FENNEC PHARMACEUTICALS INC.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 7
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Feb 20